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Abstract 
Since the Food and Drug Administration (FDA) relaxed regulations on broadcast 
DTC advertising in 1997, DTC advertising has become a prominent part of public health 
communication. The purpose of this study is to assess the stigma reducing components of 
DTC ads based on the attribution theory and recategorization theory. Taken together, the 
combination of these two health communication theories can provide a useful framework 
to assess whether DTC advertising has made a sufficient effort to reduce the barrier in an 
attempt to motivate people to take appropriate actions for their treatment. A content-
analysis of the past ten years from 1998 to 2008 of DTC ads of stigmatized diseases was 
done to critically evaluate the practice of DTC ads. Results focus on the prevalence of 
onset controllability (e.g., whether contracting an illness is blamable or not), offset 
responsibility (e.g., whether people have efforts to cope with or not) and recategorization 
(e.g., in-group) as textual cues and visual cues in the ads. Only half of ads (57%) offered 
a stigma reducing strategy. The most prevalent for both textual cues and visual cues were 
recategorization. However, an unbalance of stigma reducing components implies a 
meaning that Corrigan and Penn (1999)‟s strategy of interventions to reduce stigma could 
not effectively function. Therefore, it required appropriate adjustments by onset 
controllability, offset responsibility and recategorization.
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Introduction 
Since the Food and Drug Administration (FDA) relaxed regulations on broadcast 
DTC advertising in 1997, DTC advertising has become a prominent part of public health 
communication. Proponents claim that the contents of DTC advertising play an important 
role in providing health information to the public (Holmer, 1999; Holmer, 2002; Kelly, 
2004), while opponents argue that heavy DTC advertising has raised drug costs as well as 
unnecessary prescribing (Elliott, 2003; Findlay, 2001). Amid the heated debate, it is 
critical to assess the contents of DTC advertising to see how and to what extent they are 
constructed in a way that could benefit the public. A thorough theory-based evaluation of 
DTC advertisements can enable us to judge intended communication outcomes, 
especially their impacts on health-related beliefs. 
Given the important role of health theories to craft effective messages, scholars 
have extended the application of theories to the evaluation process in many disciplines 
(see Cappella et al., 2001; Stephenson & Quick, 2005; Stephenson, 2002). However, 
most of studies of DTC advertising (see Huh & Cude, 2004; Kaphingst & Dejong, 2004; 
Kaphingst, Dejong, Rudd, & Daltroy, 2004; Kopp & Bang, 2000) evaluated the contents 
based on the Food and Drug Administration (FDA) guidelines to see whether DTC ads 
meet the current fair-balanced components. Essential as it is to evaluate the contents for 
their adherence to the existing standards, it is also important to assess the communication 
values of DTC ads from health theory perspectives. A systematic analysis of message 
components will help generate better directions for the FDA to promote the utilization of 
DTC advertising to its full effect. Considering the ongoing debate about the pros and 
cons of DTC ads in the United States, it is time to thoroughly examine whether the DTC 
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ads consist of the necessary theoretical components to enhance the public‟s health 
outcomes. 
DTC advertising related to stigmatized disease would particularly benefit from 
theory-based evaluation of its communication value. Because stigmatized diseases are 
often under-treated, public efforts to reduce the stigma attached to these medical 
conditions are critically needed. The value of DTC ads can lie in raising awareness and 
reducing stigma as the visibility of DTC ads increases. In fact, among the top 20 most 
advertised prescription drugs, five medical conditions are often linked to high stigma: 
depression (Wellbutrin), sexually transmitted infection (Valtrex), fungal skin infections 
(Lamisil), and two kinds of erectile dysfunction (Cialis, Viagra). However, little is known 
as to whether such DTC ads contain the components to reduce stigma or not, in addition 
to promoting the brand name itself. Whether DTC ads contain theoretical components to 
reduce stigma has a direct bearing on the debate about the social benefits of DTC ads.  
The purpose of this study is to assess the stigma reducing components of DTC ads 
based on the attribution theory and recategorization theory. Taken together, the 
combination of these two health communication theories can provide a useful framework 
to assess whether DTC advertising has made a sufficient effort to reduce the barrier in an 
attempt to motivate people to take appropriate actions for their treatment. A content-
analysis of the past ten years of DTC ads of a stigmatized disease will allow us to 
critically evaluate the practice of DTC ads since the FDA loosened the broadcast 
requirements in 1997.  
 
 
3 
 
An overview of DTC advertising 
     Carrying a great deal of weight in the field of advertising, Direct-to-consumer 
(DTC) advertising is one of the most rapidly growing categories of advertising since 
1990 (Davis, 2000). Throughout the beginning of the 21
st
 century in the U.S. market, 
DTC advertising has increased to 2.5% of the total advertising expenditures and has 
become the fourth largest consumer advertising category (NIHCM, 2001; Blankenhorn et 
al., 2001). Bradley and Zito (1997) define the trends of DTC advertising into three 
categories; first, health-seeking DTC advertisements play a role in educating consumers 
about a disease or medical condition. Second, reminder DTC advertisements mention the 
name of the drug and a little information, but do not mention anything about the drug‟s 
use, effectiveness, or safety. Finally, product-specific DTC advertisements explain a drug 
therapy by name, describe its remedial uses, and represent its safety and effectiveness. 
Most advertisements show the latter category trend.  
     These DTC advertisings have provoked ongoing controversy in the U.S. 
Proponents argue that DTC advertising has fair and balanced information and therefore it 
is a good educator to consumers to increase awareness of stigmatized and under-
diagnosed diseases (Calfee, 2002; Holmer, 2002). They also argue that DTC advertising 
increases consumers‟ attention about health conditions and treatments and encourage 
them to seek more information (Allison-Ottey et al., 2003; Perri & Dickson, 1988). In 
contrast, opponents argue that DTC advertising does not have fair and balanced 
information about health benefits and risks of a drug (Bell et.al., 2000) and persons who 
lack that specialized knowledge are enticed to inquire about the marketed same drugs 
(Bradley& Zito, 1997; Hollon, 1999). 
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     Focusing on the relationship between the content of DTC advertising and its 
impact on consumer behavior, many researchers have studied DTC advertising. However, 
much scholarly attention has been paid to the results of the effects of DTC advertising 
focusing on the exposure to DTC advertising. These studies explain consumers‟ attitudes 
toward DTC advertising such as intention to visit the doctor, and requests for specific 
drugs or analyzed physicians‟ attitude toward DTC advertising. However, there are few 
studies which provide in-depth content analysis of text as a means of evaluating message 
content. 
 
Previous studies of DTC advertising with content analysis 
     A number of studies of DTC advertising have been conducted, however, 
despite a large amount of research, the current DTC studies have limited scope. Many 
studies focused on the relationships between the content of DTC advertising and 
consumers‟ behavior, yet there are not many studies about DTC advertising examining 
message components. Even though many studies treated content in DTC advertising as a 
very important issue, there has been little effort to analyze the content of existing 
advertisements. A few studies which focused on analyzing the content of DTC 
advertising and these studies can be divided into three categories. First, many content 
analyses of DTC advertising have been related to fair- balance, which evaluates whether 
fair and balanced information about the health benefits and risks of a drugs provided from 
DTC advertising meets FDA‟s “fair balance disclosure” provision, looking at whether 
DTC advertising contains well-balanced information about not only benefits but also 
risks (Abel, Lee, & Weeks, 2007; Huh & Cude, 2004; Kaphingst & Dejong, 2004; 
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Kaphingst, Dejong, Rudd, & Daltroy, 2004; Kopp & Bang, 2000). Second, there are 
some studies which examined the educational role of DTC advertising (Bell, Wilkes, & 
Kravitz, 2000; Frosch, Krueger, Hornik, Cronholm, & Barg, 2007; Kaphingst & Dejong, 
2004; Kaphingst et al., 2004). Finally, the last category of content analysis of DTC 
advertising examines types of appeals to consumer of not only television DTC 
advertising (Frosch, Krueger, Hornik, Cronholm, & Barg, 2007), but also web sites DTC 
advertising (Macias & Lewis, 2003). 
     First, one of the most important regulations of FDA is fair balance because a 
complete understanding of the advertised drug‟s benefits and risks can lead consumers to 
make the right decisions (Davis, 2000). The studies about fair-balance were conducted 
based on the FDA‟s “fair-balance disclosure” provision and this provision played a role 
in providing a basic guideline for evaluating benefit information and risk information in 
each advertising. By focusing on whether advertisings contained well-balanced 
information and how this information was presented, these studies helped consumers to 
understand the advertised drug‟s potential risks and benefits. Fair balance studies were 
conducted through website, print advertising, and television advertising. Huh and Cude 
(2004) focused on three aspects to examine the fair-balance of DTC prescription drug 
websites. Results showed that first, the type of information on DTC prescription drug 
websites was specific about risk statements in each website. Second, the imbalance 
between the amount of information about risks and benefits are revealed. In terms of 
accessibility, benefit information was more accessible than risk information. The last 
result about the completeness of risk statements showed that “more than three-quarters of 
websites did not provide numeric descriptors for the incidence level of each side effect 
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other than the information that appeared in package inserts” (p.537). Through this study, 
it is concluded that most websites draw more consumers‟ attention to benefit information 
than to risk information.  
Abel et al. (2007) examined all oncology print DTC advertising appearing in 
three patient-focused cancer magazines and other selected popular magazines in order to 
evaluate the fair-balance. They not only designed the text as benefit or risk/adverse 
effects, but also assessed the text placement as first third and/or final third. The results 
showed that benefit information was presented in the first third of text, while risk/adverse 
effect information was presented in the final third. Comparing the font size, benefit 
information was shown in larger font size than risk/adverse effect information. 
 Kaphingst et al. (2004) conducted analysis focusing on “product-specific 
advertisements appearing on the three major television network (ABC, CBS, NBC)” (p. 
517). They counted advertisements as product-specific DTC advertisement based on 
three standards; whether they advertised a prescription drug or not, whether they stated 
the name of the drug, and whether they gave at least one indication for the drug. In this 
study, the coding dimensions are grouped into three categories; the presentation of risk 
and benefit information in the ads, adequate provision for dissemination of detailed 
product information, and describing the educational content of the advertisements. The 
presentation of risk and benefit information were examined using a number of different 
aspects such as risk information in one continuous segment, speed change, tone change, 
volume change and announcements by a different announcer. This study found that most 
of advertisements did not achieve fair-balance because statements about benefits 
outnumbered statements about risks. 83% of ads presented the risk information in one 
7 
 
continuous section. Moreover, only a few ads use speed change, tone change, volume 
change and different announcer for the risk information. In another study conducted by 
Kaphingst & Dejong (2004), they also examined television advertisements. They focused 
on the amount of time a viewer has to absorb facts about risk and benefits and the lack of 
important contextual information in risk statements. They also found that most of the 
advertisements presented risk information in one continuous segment and an 
advertisement with contradictory visual and audio messages minimizes risk information 
compared with benefit information. 
     Moreover, a more recent study reviewed previous empirical studies that 
focused on the importance of fair-balance (Kopp & Bang, 2000). This study examined 
the content of benefit and risk information in DTC advertising and the content‟s impact 
on physicians and consumers. The study conducted content analysis of prescription drugs 
advertising directed toward physicians and directed toward consumers. The results 
showed that DTC advertising passed over imbalanced information, emphasizing benefit 
information over risk information. “Promotional or benefit content appears to continue to 
outweigh side effect and cautionary content, and that often the advertising does not 
comply with FDA rules” (Kopp & Bang, 2000, p.48).  
     Second, in DTC advertising, studies with content analysis which are designed 
to explore the nature of the presented information focus on the educational role of DTC 
advertising. The following studies are content analysis about fair-balance used to evaluate 
the educational role of DTC advertising. These studies assessed the effort of DTC 
advertisings which have been conducted and concluded that print advertising (Bell et al., 
2000)  as well as television advertising (Frosch et al., 2007; Kaphingst & Dejong, 2004 ; 
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Kaphingst et al., 2004) played an insufficient role in educating patients about risk factors. 
These studies showed that most of advertisings did not provide sufficient information 
about risk factors or symptoms. This causes failure of awareness among undiagnosed 
individuals. Frosch et al. (2007) used the types of factual claims about the target 
condition such as any factual information (e.g., symptoms), biological nature or 
mechanism of disease, risk factor or cause of condition, prevalence of condition, and 
subpopulation at risk for the condition. Results showed that advertisements only provide 
limited information about the causes of a disease and who is at risk.  
Bell, Wilkes, & Kravitz (2000) examined the educational value of DTC print 
advertisements by analyzing the content of DTC print advertising and conclude that DTC 
advertising has only a minimal amount of information to educate consumers. Bell et al. 
(2000) created a medical condition information index and a treatment information index 
by summing the number of medical condition codes and the number of treatment codes 
present within each advertisement. The purpose of this study was to determine whether 
each advertisement contained 5 elements of medical information conditions and 6 
elements of treatment information. The five elements of medical information condition 
are: condition name, misconceptions, precursors, prevalence, and symptoms. The six 
elements of treatment contain the competing treatments, mechanism of action, success 
rate, supportive behaviors, time to onset of action, and treatment duration. The results 
showed that among medical information conditions, the advertisements provided the 
medical condition name most often. The remaining elements ranked most to best often 
were, symptoms (sixty percent of the advertisements provided at least one symptom of 
the condition), information about precursor, information about condition prevalence, and 
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clarifications about a condition-related misconception. Among treatment information 
conditions, information about a drug‟s mechanism of action was the most presented. The 
next most dominant information was an acknowledgment of the existence of one or more 
competing treatments. Ranking third was information about supportive behaviors such as 
changes in diet, physical activity, and sleeping patterns. Fourth was information about 
time to onset of action. Fifth was about required treatment duration. The least information 
given was about success rate estimates. Comparing condition information and treatment 
information, this result revealed that, overall, condition information outweighs treatment 
information. The result of this analysis conclude that “these advertisements seldom 
educate patients about the mechanism of action by which the drug treats a particular 
condition, its success in doing so, alternative treatments, and behavioral changes that 
could argument or supplant treatment” (Bell et al., 2000, p.1096).  
In order to examine the educational content, Kaphingst et al. (2004) examined the 
use of medical versus lay terminology to express medical ideas in the advertising and 
they also examine whether they use only medical terms, lay terms or both. They also 
examined whether advertising includes contents about drug‟s effectiveness and indication 
information, information-seeking behaviors encouraged by advertisings and other key 
information. The result showed that 70% of advertisements used a combination of lay and 
medical terminology, but a majority of the advertisements did not provide information 
such as effectiveness and indication of drug. All of the advertisements contained content 
to encourage information-seeking behaviors. The results showed that the majority of the 
advertisement used medical terms. This means that those consumers with limited 
understanding of the medical terminology would have more difficulty in understanding 
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the advertisements. Macias & Lewis (2003) examined the content of the DTC 
prescription drug web sites, because understanding the use of advertising appeals can 
indicate whether the purpose of these advertisings is selling or educating. This study 
found that most websites provided much information and beneficial education of value to 
consumers. These websites played a pivotal role in guiding high-quality health 
information to consumers. 
      Finally, the last category of content analysis of DTC advertising examines 
types of appeals to consumers. Some studies of DTC advertising with content analysis 
focused on using the appeal method when examining fair-balance or educational aspects 
of DTC advertising. Many of the studies evaluated the content of each advertisement‟s 
appeal using the method of Bell et al. (2000).The studies which used Bell‟s method are 
following; Abel, Lee, & Weeks (2007), Macias & Lewis (2004). This taxonomy included 
the claimed attributes about the drug‟s effectiveness, social-psychological enhancements, 
ease of use, and safety. Bell et al. (2000) examined four sets of concerns; trends, intended 
target of these advertisements, inducements, and advertising appeals. This paper 
examined trends by examining the changes in the introduction of new brands of 
prescription drugs and classifying each of the advertisements under the calendar year in 
which it first appeared. During the 1989-1998, new advertisement and brand 
introductions dramatically increased and dermatological conditions were the most 
common brands advertised. The target audience was examined to better understand the 
promotional strategies of the drug industry. All of the advertisements were aimed at the 
potential user of the drug, but women were more often targeted. Inducements were 
examined and categorized into three types; patient support, information and financial 
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inducements. Based on the medical condition, the percentage of advertisements which 
included patient support offers, information offers, and financial incentives showed 
different trends. Advertising appeals were examined by using the table of taxonomy of 
advertising appeals. The most common appeals which were used in advertisements were 
effectiveness, symptom control, innovativeness, and convenience. Abel et al. (2007) 
examined the nature of appeals in each advertisement, considering if the advertisements 
used graphs, charts, or numbers/percentages of patients experiencing an outcome or 
adverse effects. The study also examined the effectiveness of the use of celebrities, actual 
patients or physicians and the use of patient testimonials, as well as the content of 
advertisements‟ appeals based on method of Bell et al.(2000) ; effectiveness, socio-
psychological appeals, and ease of use. The result showed that a majority of the 
advertisements included clinical trial data and an image of a patient. The most widely 
used appeals were medication effectiveness. Socio-psychological appeals and ease of use 
medication were contained in about half of advertisements. 
 Macias and Lewis (2004) also examined the DTC prescription drug websites 
using the method of Bell et al. (2000) to understand the use of advertising appeals. They 
used the condition medical information codes and treatment information codes which 
were created by Bell et al. (2000). The result was similar to the result in print 
advertisements studies conducted by Bell et al.(2000), but appeals used in websites 
showed  more monetary incentives and much more medical and drug information. Frosch 
et al. (2007) conducted the content analysis of television DTC advertising focusing on 
how they attempt to appeal to consumers, in order to examine the educational purposes of 
television DTC advertisings. The types of appeals to viewers such as rational, positive 
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emotional, negative emotional, humor, fantasy, sex, and nostalgia were examined. 
Moreover, using what Frosch et al. (2007) termed “lives of characteristics”, they 
examined how the advertisements portray the role of medication and healthy lifestyle 
behavior. While negative emotional appeals were used in sixty-nine percent of 
advertisements, positive emotional appeals still outweighed the total negative, when the 
combination of using both negative and positive appeals in the same message are factored 
in. 
     These previous studies of DTC advertising with content analysis show that 
these studies are categorized broadly with three categories such as fair and balance, 
educational information of DTC advertising, and appeal method based on FDA 
guidelines. These studies focused on the text with benefits and risks content, educational 
information, and the appeal of advertising with various categories or standards of content 
of advertising. Therefore, the fact that the nature of DTC advertising had been ignored in 
studies prior to those done by Bell et al. (2000). Bell et al. (2000) provided initial 
understanding of the influential characteristics of DTC advertising that have motivational 
effects leading to consumers to communicate with physicians about medications. 
However, this study had the limitation of not being based on theoretical framework. 
Given the various standards of content analysis, previous content analysis is not sufficient 
to evaluate the content of DTC advertising. However, there has been little analytical 
research assessing the DTC advertising contents based on the health communication 
theory. Even fewer have focused on a single drug category- stigmatized drug (e.g., 
antidepressant, sexually transmitted infection, fungal skin infections and erectile 
dysfunction). Therefore, more effort is needed to analyze the content of DTC advertising, 
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grounded in the health communication in order to facilitate the use of DTC advertising in 
educating consumers.  
 
Background 
Understanding the stigma with illness 
 Goffman (1963) described stigma as undesirable or discrediting characteristics 
which are linked to a flaw of immorality. According to Goffman‟s construction of stigma, 
society was dichotomized into „normal‟ people and people who have discrediting 
attribute(s), that is, a stigma.  Stigma can be divided into social stigma related to overt 
discrimination and self-stigma toward themselves (Corrigan & Watson, 2002). Stigma 
related to overt discrimination is the way the public views individuals with illnesses as 
being unpredictable and dangerous. Self-stigma, also called internal stigma or perceived 
stigma, is a form of reaction which stigmatized individuals have toward themselves (King 
et al., 2007).  
These two kinds of stigma function as a barrier for continuing health treatment 
and seeking information such as in case of mental illness (Sirey, Bruce, & Raue et al., 
2001) and sexually transmitted infection diseases (Barth et al., 2002). Some consumers 
who have depression (Sirey et al., 2001) or a sexually transmitted infection (Barth et al., 
2002) are silenced by social stigma, and hesitate to discuss their diseases or to seek 
information. Moreover, Sirey et al. (2001) revealed that people who have lower 
perceived stigma showed better adherence to the recommended medication regimen. 
Therefore, a better understanding of the mechanism underlying stigma reduction and 
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contriving appropriate strategies may enable us to identify important targets for clinical 
intervention to improve adherence and ultimately reduce under-treatments.  
 
The lack of theory-driven stigma reducing strategy  
Corrigan and Penn (1999) designed the strategy of interventions to reduce stigma 
which focused on three areas: education, contact, and protest. Efforts to provide 
familiarity with the stigmatizing condition through education (increasing knowledge 
about illness), contact (with people who have the stigmatized condition), and protest 
(telling those who take negative attitude toward the condition to stop) can reduce stigma. 
Especially, contact is described as both direct (e.g., face-to-face) and indirect (e.g., the 
media) interactions between public and persons affected in order to reduce stigmatizing 
attitude. 
As shown in the previous studies, there have been content analyses of DTC 
advertising as just an educational role (Bell et al., 2000; Frosch et al., 2007; Kaphingst & 
Dejong, 2004; Kaphingst et al.,2004), but the educational contents of these studies did 
not include mechanism of stigma reduction.  Ball, Liang, and Lee (2008) explored DTC 
television advertisements based on the Corrigan and Penn‟s (1999) approaches to reduce 
the stigma-education and contact. However, given the lack of identifying specific change 
mechanisms of reducing stigma based on the theories, by stepping further into the 
education and contact strategy of Corrigan and Penn, this study evaluates specific 
strategic components based on the attribution theory and the recategorization theory. 
These two theories will be able to present the mechanism of how education and contact 
strategy can reduce stigma.  
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The attribution theory 
The attribution theory is based on the assumption that individuals tend to look for 
causal understanding of all events (Weiner, 1980). This theory has been broadened to the 
study of social stigma and reactions to social stigma (Weiner et al., 1988). People have a 
tendency to search for causes of disease in a person and decide on their behavioral 
reaction to a person with a stigmatized condition (Rush, 1998). Therefore, this theory can 
explain that how an individual‟s attribution about others with illness affects the formation 
of stigma. Even though various internal and external dimensions make attribution, the 
controllability dimension especially is linked to perception of a person with stigmatized 
illness. 
Controllability which is related with the concept of responsibility is one of the 
dimensions of perceived causality in attribution theory (Weiner, 1986). Controllability is 
defined as perceptions of the stigmatized individual when they are responsible for the 
condition or when the condition could be removed by the behavior of the stigmatized 
individual (Crocker et al., 1998). Controllability can be further distinguished into two 
components: responsible perception for the inception and the perpetuation of their 
stigmas. These two components are referred to as onset controllability (e.g., whether 
contracting an illness is blamable or not) and offset controllability (responsibility) (e.g., 
whether people have efforts to cope with or not) (Corrigan, 2000; Schwarzer & Weiner, 
1991). Even though onset controllability and offset controllability are not independent, 
this study proposes that onset controllability and offset controllability separately 
contribute to perceive stigmas of the individuals.  According to some studies, onset-
controllable stigmas are related to affective reactions of no pity, little liking, and anger 
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(Weiner et al., 1988).  On the other hand, uncontrollability attributions about an event can 
evoke pity and helping behavior (Schmidt & Weiner, 1988; Zucker & Weiner, 1993).  
Bergman and Chalkey (2007) examined the relationship between stickiness 
(retention) of stigma and controllability about dirty work. Stickiness can only occur when 
a stigma has been removed (Bergman & Chalkey, 2007). In high offset controllability 
situations, if the individual worked in a dirty job for a long time, this would be treated 
that the individual wants to do the work. Having high offset controllability increases 
likelihood of stigma. However, when offset controllability is low, despite of the high 
tenure of their attribution, the retention of stigma is relatively low.  
Mental illness is treated as more controllable than physical illness by people 
(Weiner et al., 1988). This attribution makes people with stigmatized illness take 
responsibility and mental illness is more stigmatizing (Corrigan, 2000). In the case of 
erectile dysfunction, until 1970s, there was a perception that the cause of erectile 
dysfunction was psychological in origin (Melman, & Gingell, 1999). This erectile 
dysfunction condition reduced individuals‟ self esteem and affected their relationships 
according to the Impotence Association survey (1997). However, many researches 
focused on the mechanism and provided the knowledge of the physiology of erectile 
dysfunction (see Moreland, Hsien, Nakane, & Brioni., 2001).  
Weiner et al. (1988) examined the effects of manipulated perception of causal 
controllability. The results showed that a shift of attribution produced more positive 
affective and help-related reactions. As such, if people believe that the causes of mental 
illness are out of the control of individuals, their reactions to the mental illness will be 
less negative. Therefore, a shift in attribution from controllable to uncontrollable can help 
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to reduce stigma. Uncontrollability attributions are the key component of education 
which leads people to evoke more public sympathy and to reduce stigma. Educating 
people about biological concepts and biomedical explanations about mental illnesses such 
as neurotransmitter depletion can change attribution from controllable to uncontrollable 
at onset. For example, some studies of obesity based on attribution theory showed that 
educating people about the biological, generic, and uncontrollable reasons for obesity 
could change attitudes toward obese people (Crandall, 1994; Wiese, Wilson, Jones & 
Neises, 1992). Crandall (1994) studied attitudes of adult participants toward obese people 
by targeting the controllability of obesity, rather than general knowledge about obesity. A 
persuasive message which explained the reason of obesity by uncontrollable 
physiological/metabolic and generic factors was able to change people‟s beliefs about the 
controllability and reduce adults‟ negative attitude toward obese people. A similar study 
of Anesbury and Tiggemann (2000) was conducted by targeting children. The result 
showed that education of metabolic factors could reduce children‟s beliefs about the 
controllability of obesity toward obese people.  Therefore, biogenetic explanation will 
help to reduce stigma by the public as well as self-stigma. 
However, the studies are insufficient to determine if stigma onset is the sole 
determinant of affective and behavioral reactions toward the stigmatized (Schwarzer & 
Weiner, 1991). In terms of offset controllability, Schwarzer and Weiner (1991) suggested 
coping effort as an important determinant of affective and behavioral reactions of others. 
This study conducted an experiment to explore the effects of onset controllability and 
coping efforts on blame and emotions such as pity, anger and social stress. This study 
compared the effects of perceived onset causality with perceived coping efforts on 
18 
 
affective reaction and behavioral judgments towards the stigmatized. Coping effort is 
manipulated with sticking to a healthy diet and adhering to medication prescribed by 
doctors. Results showed that a person with onset uncontrollable and high coping effort 
evoked high pity. People who did not cope were blamed more than those who were 
coping.  
When these two attributions are correlated to DTC advertising, onset 
controllability can be applied as informing cause of illness/uncontrollable. However, 
because coping effort is a person‟s real effort, ads cannot directly cover this offset 
responsibility attribution. Therefore, Offset responsibility is defined as person‟s own will 
to cope with or overcome the stigmatized medical condition or efforts to cope with the 
condition except for taking medicine.  
 
The recategorization theory 
The recategorization theory explains how contact can reduce stigma. Meeting 
persons with stigma is able to diminish stigma (Holmes et al., 1999; Link & Cullen, 
1986). According to Link and Phelan (2001), people label human differences and 
separate „us‟ from „them‟. This labeling causes the stigma. The mere categorization of 
people into in-groups and out-groups cause differentiation between the in-group and out-
group and leads to seeing the in-group as favorable (Devine, 1995). This group boundary 
leads to perceptual biases and discrimination (Devine, Plant & Harrison, 1999). Contact 
with out-group members enables people to change behaviors toward out-groups from 
„them‟ to „us‟ by blurring the intergroup boundaries through decategorization (Brewer & 
Miller, 1984). Under decategorization, people are recognized as more differentiated 
19 
 
individuals, personal interaction is performed, and attraction is decided by personal 
characteristics and actual interpersonal similarities. The Common Ingroup Identity Model 
can further explain the additional process that influences the perception of group 
boundaries through recategorizaton. According to recategorization, people who are 
involved in separate groups recognize themselves as a member of common superordinate 
category including former in-group and out-group members (Gaertner & Dovidio, 2000; 
Gaertner, Dovidio, Anastasio, Bachman, & Rust, 1993). That is, this model can explain 
that the process of recategorization establishes more harmonious intergroup relation.  
Many empirical studies revealed that categorization of a person as in-group 
members rather than out-group members produced more positive evaluations (Brewer, 
1979) and perceptions of shared beliefs (Brown, 1984). It also enhanced memory for 
positive information about others (Howard & Rothbart, 1980) and reduced attributions of 
personal responsibility for negative outcomes (Hewstone, Bond, & Wan, 1983). Nier, 
Gaertner, Dovidio et al. (2001) conducted studies which examined whether developing a 
common in-group identity among Blacks and Whites can improve Whites‟ interracial 
evaluations. The result showed that when Whites interacted with Blacks as members of 
the same group rather than as separate individuals, they were more favorable to Blacks. 
Intergroup contact which is designed to produce a recategorization of people from out-
group to in-group can reduce bias (Sherif et al., 1961).  
Then, how can vicarious contact through advertisements reduce stigma without 
personal or direct contact? Vicarious contact is defined as a person‟s subjective feeling 
that he or she has personal relationship similar to direct contact through mass media 
(Herek & Capitanio, 1997). Corrigan, Larson, Sells, Niessen, & Watson (2007) examined 
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the impact of not only indirect education, but also indirect contact, in order to examine 
whether these two programs reduce stigma or not. Results showed that even though 
indirect education had limited effects, indirect contact impact was significant. Devine and 
Hirt (1989) said that campaigns such as indirect contact are able to develop behavior 
change. For example, many studies which examined the effects of vicarious contact were 
extensively conducted, since Earvin “Magic” Johnson revealed his HIV infection in 1991. 
His announcement promoted public awareness about AIDS and to motivate AIDS 
education (Stevenson, 1991). This celebrity self-disclosure by vicarious contact showed 
an effect similar to direct contact (Kalichman, Russell, Hunter & Sarwer, 1993). A 
reduction in AIDS stigma is able to be expected as more celebrities disclose their HIV 
status or AIDS diagnosis. Vicarious contact has its greatest impact on those individuals 
who have the highest levels of stigma (Herek & Capitanio, 1997). Moreover, Herek & 
Capitanio (1997) assessed that whether direct contact and vicarious contact with a person 
with AIDS (PWAs) do indeed have similar effects on public attitudes toward AIDS and 
levels of stigma directed at PWAs. Both contacts affect to reduce stigma, but the results 
showed that all of the different stigma variables indicated that vicarious contact was 
associated with higher, albeit diminishing, stigma, while direct contact was associated 
with low or decreasing levels of stigma. As shown the example of “Magic” Johnson, it is 
proven that not only vicarious contact through mass media, but also developing person 
with stigma as common in-group member is effective to reduce stigma.  
Therefore, efforts which change people with stigmatized diseases from „them‟ to 
„us‟ or from „out-group‟ to „in-group‟ can be a strategy to reduce stigma. Corrigan et al. 
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(2002) suggests that “combining education with contact with a person with mental illness 
can enhance the effects of an intervention” (Corrigan & Watson, 2004 p.478). 
 
Visual cues and textual cues in DTC advertising 
Effective messages to influence people can be created based on theories. This 
paper considers both the textual and the visual cues of the persuasive health message in 
stigma DTC advertising, based on variables of the attribution theory and the 
recategorization theory. Even though nonverbal cues have outweighed verbal cues in 
interpreting interaction (Birdwhistell, 1955) and have potential power, there has been 
little study of visual cues in DTC advertising (see Cline& Young, 2004; Grow, Park & 
Han, 2006). Visual cues play a role in thinking peripherally through photographs, 
depicted people, and their characteristics, while text focuses on issue-relevant thinking 
such as medical condition, symptoms, diagnosis, appropriate treatment and management, 
and risk of treatment (Cline & Young, 2004).  In other words, visual cues and textual 
cues play a reciprocal role.  
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Research Questions 
RQ1: What components of reducing stigma are most prevalent in DTC 
print ads via textual cues? 
 RQ 2: Are there significant differences of textual components of reducing 
stigma among medical conditions of DTC advertising? 
RQ3: What components of reducing stigma are most prevalent in DTC 
print ads via visual cues? 
RQ4: Are there significant differences of visual components of reducing 
stigma among medical conditions of DTC advertising? 
 
Method 
     A content analysis was conducted to evaluate the content of DTC advertising 
that may function to reduce stigma. 
 
    Sample Materials 
    In the current study, a print advertisement is defined as either a “single page” 
advertisement or a “spread” (two pages facing one another). This paper only analyzes a 
print advertisement except for the additional page listing the brief summary as required 
by the FDA. 
Advertisements were collected from a popular magazine from January of 1998 to 
December of 2008 through microfilm. Time magazine has been selected because of its 
high circulation. It is one of top magazines according to Advertising Age (2006). In 
addition, among top circulation magazines, Time services the general population (men 
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50% and women 50%) without being skewed toward men or women (Anon, 1998). 
Among general readership magazines, Time has the highest circulation (Anon, 1998). 
Because of these reasons, this magazine was selected as a representative of consumer 
magazines.  
The sample included products which are related to medical conditions with high 
levels of stigma among the top 20 pharmaceutical products in terms of spending on 
Direct-to-Consumer advertising in 2005 (Donohue, Cevasco, & Rosenthal, 2007). They 
included sexually transmitted diseases (e.g., genital herpes and Human Papillomavirus 
infection) (Valtrex), depression (Wellbutrin), fungal skin infection (Lamisil) and erectile 
dysfunction (Cialis, Viagra). Moreover, according to the pharma report 2008 (Medical 
Marketing & Media), bipolar disorder (Seroquel) and anxiety disorder (Effexor XR) are 
included in the top 20 pharmaceutical drugs by US sales in 2007. In terms of top 20 
therapeutical categories by US sales in 2007, antipsychotics are ranked to third and anti- 
depression is ranked to fifth. Based on these reports, this study categorized stigmatized 
diseases as mental illness (Anti-depression, bipolar disorder, Alzheimer‟s disease, 
Attention-deficit hyperactivity disorder (ADHD), anxiety disorder) (Sirey, Bruce, & Raue, 
et al.,2001),vaginal disease (Centers for Disease Control and Prevention,2004), fungal 
skin infection (Tarango, 2007) and erectile dysfunction (ED) (the Impotence Association 
survey, 1997). A sample was drawn from these 4 categories of stigmatized diseases print 
advertisements, and was defined as 8 types of medical conditions by subdividing mental 
illness into 5 types.  
There were a total of 228 DTC advertisements related to stigmatized medical 
conditions in the study: anti-depression (32), bipolar disorder (31), Alzheimer‟s disease 
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(26), ADHD (14), anxiety disorder (2), vaginal disease (4), fungal skin infection (28), 
erectile dysfunction (91). Each advertisement was counted only once when 
advertisements are repeated across magazines. Repeated ads were eliminated. Moreover, 
the criteria for classifying ads followed visual images. This study excluded 
pharmaceutical companies‟ advertisements which do not mention a specific drug. 
Therefore, the selected 79 samples showed totally different visual images.  
The sample process yielded 85 kinds of DTC advertisements for 19 drugs 
addressing 8 types of medical conditions. However, because of illegibility of microfilm 
of 6 kinds of DTC advertisements (5 kinds of Viagra, 1 kind of Effexor XR), these ads 
were eliminated. Therefore, this study examined contents of 79 advertisements. 
 
Definition of stigma reducing variable 
1. Education  
Education is operationally defined as information about onset controllability and 
offset responsibility. Onset controllability is defined as biological concept and biomedical 
explanation. This is an effort that explains uncontrollable attribution at onset. Offset 
responsibility is defined as person‟s own will to cope with or efforts to overcome medical 
condition except for taking medicine. 
2. Contact 
 Contact is operationally defined as the effort an individual with an illness makes 
to be part of an in-group, or inversely to remain detached from illness. If an 
advertisement has the „us‟ concept or „in-group‟ concept visually or verbally, this is 
coded as contact.  For example, if the ads verbally mention “You are not alone”, this is 
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defined as „us‟ concept. In visual cues, if visual cues depict a social relation with other 
people, this is treated as „us‟ and is defined as contact.  
 
Measurement 
To operationalize the dimension of reducing stigma message strategies, this study 
created a coding scheme and combined the Cline & Young‟s (2004) visual cues in order 
to fit the items into the content analysis of stigmatized disease DTC ads as “former health 
communication message strategies.” This study grouped the coding dimensions into two 
categories: controllability (onset controllability and offset responsibility) and 
recategorization (from „them‟ to „us‟). 
 
Coding systems 
1. Controllability 
1) Onset controllability 
Onset controllability is defined as biological concept and biomedical explanation. 
In textual cues, if the ad explains the cause of illness as biological or biomedical problem, 
this was coded as onset controllability.  In visual cues, first, if a picture uses the 
depictions of biological organs or symptoms, this was coded as onset controllability. 
Second, if a graphic framing of disease as chemically bound is shown, this was coded as 
onset controllability. Third, if the cause of illness is explained by symbolically 
informational medicalized diagram, this was coded as onset controllability.  
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2) Offset responsibility 
Offset responsibility is defined as person‟s own will to cope with or overcome the 
stigmatized medical condition or efforts except for taking medicine. Offset responsibility 
is divided into two concepts. The first is implied coping efforts and the second is direct 
coping efforts. In textual cues, first, if the ad explains the way of treatment on the 
assumption that a patient has tried on manage the stigmatized condition, this will be 
coded as implied coping efforts. For example, if ads asks “Are you looking for a way, 
because current treatment isn‟t effective?”, this sentence has implied this patient has been 
coping with this condition. Second, if the ad expressed directly patient‟s coping effort, 
this will be coded as direct coping effort. For example, if ads says “ I  have tried to 
overcome this condition.”, this ad is directly showing a patient‟s coping effort. In visual 
cues, if ads depict a person who is exercising or getting therapy, this will be treated as 
offset responsibility.  
2. Recategorization 
In textual cues, first, if the content contains the meaning of „we, our, us‟ or 
„You‟re not alone,‟ this was coded as recategorization. Using the „we‟ is treated as 
emphasizing in-group membership. Second, if there is verbal expression containing 
inclusion like “join”, this will be also coded as recategorization. In visual cues for ads, 
coders coded social or relational context based on Cline and Young‟s (2004) visual cues. 
Depicting social and relational context can express that boundaries between groups is 
blurred and an individual with stigma is an in-group member. Moreover, this also means 
“join” similar to textual cues. First, social context is defined as a picture where there are 
two or more people; family (depicting people from two generations), romance (depicting 
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only two people engaged in embracing or mutual gazing), work (reflected in work-related 
clothing and/or equipment), recreational (relaxing), or other (indeterminate). Second, 
relational context is defined based on the number of people depicted: alone, dyad, or in a 
group.  
 
Coding processes 
Coders were trained to implement the coding system by reviewing the coding 
manual and practicing sessions that established acceptable inter-coder reliability levels.  
Coders independently coded the randomized sample of 79 advertisements. In 
addition, 20% of ads were randomly selected for the purpose of assessing reliability. 
Inter-coder reliabilities ranged from Cohen‟s kappas of 0.81 to 1.00 for nominal data. 
Inter-coder reliabilities reported as Cohen‟s Kappas were as follows: Types of 
visual cues (1.00), visual onset controllability (1.00), visual offset responsibility (0.94), 
visual recategorization social context (1.00), visual recategorization relational context 
(1.00), types of textual cues (0.89), textual onset controllability (0.89), textual offset 
responsibility (0.90), textual recategorization (0.81).  
 
Data analysis 
This study used the advertisement as units of analysis. Data were analyzed in the 
forms of descriptive statistics and cross-tabulations. Chi-square analysis also was used.  
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Results 
Data were analyzed in terms of presence of onset controllability, offset 
responsibility and recategorization. Results were separately reported for the visual cues 
and textual cues.  
 
Descriptive statistics 
This study included a sample size of 79 advertisements in Time magazine. 
Stigmatized disease ads were categorized into 8 types of disease conditions.  5 brands of 
Anti-depression drug were advertised: Prozac, Paxil, Cymbalta, Wellbutrin and Zoloft. 
Bipolar disorder drug included 2 brands: Abilify and Seroquel. Alzheimer‟s disease was 
only advertised by 1 brand: Aricept. ADHD included 3 brands: ADDRALL XR, Vyvanse 
and Strattera. Anxiety disorder included 2 brands: BuSpar and Effexor XR. However, 
because of illegibility of microfilm advertisements, Effexor XR was dropped. Vaginal 
disease included 3 brands: Diflucan, Gardasil, and PREMPRO. Fungal skin (nail) 
infection included 1 brand: Lamisil. Erectile Dysfunction (ED) included 3 brands: Viagra, 
Cialis, and Levitra (See Table 1). 
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Table 1-Descriptive statistics for category of drug 
 
 
  
Brand 
  
Number 
of Ads 
  
 
 
 
 
 
Category 
Of  
Drug 
 
 
 
 
 
 
Total 
 
Anti- 
depression 
 
Bipolar  
Disorder 
 
Alzheimer‟s  
Disease 
 
ADHD 
Anxiety  
Disorder 
 
Vaginal  
Disease 
 
Fungal skin 
infection 
Erectile  
Dysfunction 
 
5 
2 
1 
3 
1 
3 
1 
3 
19 
  
15 
6 
10 
8 
1 
4 
4 
31 
79 
  
 
The first RQ asked, “What components of reducing stigma are most prevalent in 
DTC print ads via textual cues?”  This study found that 17 ads offered onset 
controllability, 11 ads offered offset responsibility, and 26 ads offered recategorization. 
Among the total 79 ads, these occupied as onset controllability (21.5%), offset 
responsibility (13.9%), recategorization (32.9%) (See Table 2). Among 79 ads, 34 ads did 
not offer any kinds of textual cues at all (43%). Therefore, 57% of ads offered stigma 
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reducing components as textual cues. However, among these 34 ads, 18 ads offered 
visual cues (e.g., onset controllability, recategorization). Therefore, 16 ads did not offer 
any kinds of stigma reducing component neither textual cues nor visual cues (See Table 
3).  
 
 
Table 2- Prevalence of textual cues (total ads =79) 
                                                     
                                                             Category of textual cues 
 
                                   Onset               offset            recategorization              Not at all 
 
Ads N                             17                          11                       26                         34 
Percentage                21.5%                    13.9%                 32.9 %                      43% 
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Table 3- Descriptive statistics for ads without stigma reducing components 
 
 
 
 
 
 
 
Brand 
 
                                
 
          Number  
           of Ads 
 
 
 
 
Did not contain 
any kinds of stigma cues, 
either textual cues or 
visual 
 
 
Total                                    
 
Cymbalta 
Strattera 
BusPar 
              PREMPO 
Lamisli 
Viagra 
Levitra 
 
 
 
 
4 
1 
1 
1 
1 
7 
1 
16 
 
 
        
Contain  
visual cues  
only 
 
Total 
 
Aricept 
ADDRALL XR 
Vyvanse 
Viagra 
 
  
7 
2 
2 
7 
18 
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Comparison of textual cues among medical conditions 
The second RQ asked: “Are there significant differences in textual components of 
reducing stigma among medical conditions?” 
Onset controllability. Onset controllability was explained as cause of illness being 
either biological, biomedical or attribution change such as irrational thoughts or 
inappropriate thoughts. Onset controllability was offered by 17 ads in four medical 
conditions: anti-depression (10), Erectile Dysfunction (3), vaginal disease (2) and bipolar 
disorder (2) (See Table 4). 
Among textual onset controllability components, biological or biomedical concept 
occupied 85% and change attribution occupied 15% (See Table 5). All of the ads which 
offered onset controllability offered uncontrollable biological or biomedical concept. 
Especially, 3 Prozac ads offered both biological concept and change attribution. 
To compare the presence of onset controllability among medical conditions, a chi-
square analysis was also conducted. The results (See Table 4) showed that the onset 
controllability was significantly different among (at the p <0.05 level) medical conditions. 
Anti-depression ads with onset controllability (66.7%) were shown more often than 
vaginal disease ads (50%) and bipolar disorder ads (33.3%).  
Each brand of the anti-depression ads (Prozac, Paxil, Cymbalta, and Zoloft) 
offered onset controllability except for Wellbutrin.  
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Table 4- Textual onset controllability by medical condition 
  
Medical condition 
 
 Anti-
depressio
n 
 
 
N 
Percent 
Bipolar 
disorder 
 
 
 
N 
Percent 
Alzheimer‟s 
disease 
 
 
 
N 
Percent 
ADHD 
 
 
 
 
N 
Percent 
Anxiety 
disorder 
 
 
 
N 
Percent 
Vaginal 
disease 
 
 
 
N 
Percent 
Fungal 
skin 
infection 
 
 
N 
Percent 
Erectile 
dysfunction 
 
 
 
N 
Percent 
 
total 
 
Yes 
 
 
 
10 
66.7% 
 
2 
33.3% 
 
0 
0 
 
0 
0 
 
0 
0 
 
2 
50% 
 
0 
0 
 
3 
9.7% 
 
17 
21.5% 
No 
 
 
5 
33.3% 
4 
66.7% 
10 
100% 
8 
100% 
1 
100% 
2 
50% 
4 
100% 
28 
90.3% 
62 
78.5% 
Total 15 
100% 
6 
100% 
10 
100% 
8 
100% 
1 
100% 
4 
100% 
4 
100% 
31 
100% 
79 
100% 
 
 Chi-square = 29.402 (df =7, p=.000) 
 
Table 5- Prevalence of textual onset controllability 
 
Textual onset controllability 
                                     Biological concept                Change attribution            Total 
 
N                                  17                                         3                                   20 
Percentage                   85%                                    15%                             100% 
 
 
Offset responsibility. Offset responsibility was explained as a will to cope with a 
medical condition. Among 79 ads, 11 ads offered offset responsibility: anti-depression 
(1), bipolar disorder (4), Alzheimer‟s disease (2), ADHD (1), fungal skin infection (2), 
erectile dysfunction (1). In terms of a portion of offset responsibility content in each 
medical condition, offset responsibility was occupied in each medical condition: anti-
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depression (6.7%), bipolar disorder (66.7%), Alzheimer‟s disease (20%), ADHD (12.5%), 
fungal skin infection (50%), erectile dysfunction (3.2%) (See Table 6). 
Among 11 offset responsibility components, 6 ads depicted implied coping efforts 
and 5 ads offered direct coping efforts. Implied coping efforts were found as follows: 
“Are you still using OTC brush-on remedies or messy surface creams to treat your 
infection nails? (Lamisil)”, “Unlike clippers or surface treatments you try on your own, 
(Lamisil)”, “Can your medicine do all that? (Wellbutrin)”, “ If your child‟s current 
therapy isn‟t making the difference you hoped for, talk to your doctor today about 
ADDRALL XR (ADDRALL XR)”, “You want to move forward with treatment to help 
stabilize your mood swings (Abilify).” Direct coping efforts were found as follows: “I 
love my life way too much to just hand it over to Alzheimer‟s. When my memory started 
failing, I knew I had to see my doctor (Aricept)”, “You‟ve spent years trying to manage 
the extreme ups and downs with mood swings and relapses (Abilify)” (See Table 7). 
To compare the presence of offset responsibility between medical conditions, a 
chi-square analysis was also conducted. The results (See Table 6) showed that there was 
a significantly difference between (at the p <0.05 level) medical conditions. Bipolar 
disorder (66.7%) and fungal skin infection (50.0%) offered offset responsibility more 
often than anti-depression (6.7%) and erectile dysfunction (3.2%).  
 
 
 
 
 
 
35 
 
Table 6- Textual offset responsibility by medical condition 
  
Medical condition 
 
 Anti-
depression 
 
 
N 
Percent 
 
Bipolar 
disorder 
 
 
N 
Percent 
Alzheimer‟
s disease 
 
 
N 
Percent 
ADHD 
 
 
 
N 
Percent 
Anxiety 
disorder 
 
 
N 
Percent 
Vaginal 
disease 
 
 
N 
Percent 
Fungal 
skin 
infection 
 
N 
Percent 
Erectile 
dysfunction 
 
 
N 
Percent 
total 
 
Yes 
 
 
1 
6.7% 
 
4 
66.7% 
 
2 
20.0% 
 
1 
12.5% 
 
0 
0% 
 
0 
0% 
 
2 
50.0% 
 
1 
3.2% 
 
 
11 
13.9% 
No 14 
93.3% 
2 
33.3% 
 
8 
80.0% 
7 
87.5% 
1 
100% 
4 
100% 
2 
50.0% 
30 
96.8% 
68 
86.1% 
Total 15 
100% 
6 
100% 
10 
100% 
8 
100% 
1 
100% 
4 
100% 
4 
100% 
31 
100% 
79 
100% 
Chi-square =23.019 (df =7, p= 0.002) 
 
Table 7- Prevalence of textual offset responsibility 
 
Textual offset responsibility 
                                     Implied coping effort                Direct coping effort            Total 
 
N                                   6                                                  5                                    11 
Percentage                54.5%                                       45.5%                             100% 
 
 
Recategorization. Recategorization was suggested in all medical conditions 
except for 1 medical condition: anxiety disorder. Recategorization was offered by 26 ads: 
anti-depression (5), bipolar disorder (3), Alzheimer‟s disease (3), ADHD (4), vaginal 
disease (1), fungal skin infection (1) and Erectile Dysfunction (9). A portion of 
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recategorization content in each medical condition was occupied as followed: anti-
depression (33.3%), bipolar disorder (50.0%), Alzheimer‟s disease (30.0%), ADHD 
(50.0%), vaginal disease (25.0%), fungal skin infection (25.0%) and Erectile Dysfunction 
(29.0%) (See table 8).  
Among textual recategorization components, we or you‟re not alone concept was 
offered in 23 ads, and 8 ads offered “join” concept as recategorization textual cues (See 
Table 9).  
 To compare the presence of recategorization among medical conditions, a chi-
square analysis was also conducted. The results (See Table 8) showed that there was no 
significantly different between (at the p <0.05 level) medical conditions. Therefore, we 
could not find any difference in the presence of recategorization. 
 
Table 8- Textual recategorization by medical condition 
  
Medical condition 
 
 Anti-
depression 
 
 
N 
Percent 
 
Bipolar 
disorder 
 
 
N 
Percent 
Alzheimer‟s 
disease 
 
 
N 
Percent 
ADHD 
 
 
 
N 
Percent 
Anxiety 
disorder 
 
 
N 
Percent 
Vaginal 
disease 
 
 
N 
Percent 
Fungal  
skin 
infection 
 
N 
Percent 
Erectile 
dysfunction 
 
 
N 
Percent 
total 
 
Yes 
 
 
 
5 
33.3% 
 
3 
50.0% 
 
3 
30.0% 
 
4 
50.0% 
 
0 
0 
 
1 
25.0% 
 
1 
25.0% 
 
9 
29.0% 
 
26 
32.9% 
No 
 
 
10 
66.7% 
3 
50.0% 
7 
70.0% 
4 
50.0% 
1 
100% 
3 
75.0% 
3 
75.0% 
22 
71.0% 
53 
70.9% 
Total 15 
100% 
6 
100% 
10 
100% 
8 
100% 
1 
100% 
4 
100% 
4 
100% 
31 
100% 
79 
100% 
 
Chi-square =2.820 (df =7, p= .901) 
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Table 9- Prevalence of textual recategorization 
 
Textual recategorization 
                                     We, You‟re not alone                        Join                           Total 
 
N                                      23                                               8                                  31 
Percentage                    74.2%                                          25.8%                         100% 
 
 
 
Comparison of visual cues between medical conditions 
The third RQ asked: “What components of reducing stigma are most prevalent in 
DTC print ads via visual cues?” The most common ads depicted recategorization (45.6%). 
This study found that 4 ads offered onset controllability and 36 ads offered 
recategorization. Among total 79 ads, these occupied as onset controllability (5.1%) and 
recategorization (45.6%). However, offset responsibility was not depicted as visual cues 
(See Table 10).  
Compared with textual cues, onset controllability and offset responsibility visual 
cues were less depicted less than textual cues. However, visual cues depicted 
recategorization more than textual cues.  
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Table 10- Prevalence of visual cues (total ads =79) 
                                                     
                                                             Category of visual cues 
 
                                                   Onset                 offset              recategorization                   
 
Ads N                                         4                          0                               36                                         
Percentage                               5.1%                    0%                            45.6% 
 
 
The fourth RQ asked: “Are there significant differences in visual components of 
reducing stigma among medical conditions?” 
Onset controllability. Onset controllability was depicted in only two categories of 
drugs: anti-depression (2) and bipolar disorder (2). Because only two medical conditions 
depicted onset controllability, chi-square analysis could not be conducted (See Table 11).  
The Zoloft ads, which are one of the anti-depression drugs, only offered visual 
onset controllability among brands. The Zoloft ads depicted a symbolic medicalized 
diagram as visual onset controllability (50%). On the contrary, the Abilify ads, which are 
one of the bipolar disorder drugs, depicted biological organs as visual onset 
controllability (50%) (See Table 12). 
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Table 11- Visual onset controllability by medical condition 
  
Medical condition 
 
 Anti-
depression 
 
 
N 
Percent 
 
Bipolar 
disorder 
 
 
N 
Percent 
Alzheimer‟s 
disease 
 
 
N 
Percent 
ADHD 
 
 
 
N 
Percent 
Anxiety 
disorder 
 
 
N 
Percent 
Vaginal 
disease 
 
 
N 
Percent 
Fungal 
skin 
infection 
 
N 
Percent 
Erectile 
dysfunction 
 
 
N 
Percent 
Total 
 
 
Yes 
 
 
 
2 
13.3% 
 
2 
33.3% 
 
   0 
   0 
 
0 
0 
 
0 
0 
 
0 
0 
 
0 
0 
 
0 
0 
 
4 
5.1% 
No 13 
86.7% 
4 
66.7% 
  10 
  100% 
8 
100% 
1 
100% 
4 
100% 
4 
100% 
31 
100% 
75 
94.9
% 
Total 15 
100% 
6 
100% 
  10 
  100% 
8 
100% 
1 
100% 
4 
100% 
4 
100% 
31 
100% 
79 
100% 
 
 
Table 12- Prevalence of visual onset controllability 
 
Visual onset controllability 
                           Biological organ      Graphic framing    Symbolic medicalized      Total 
                                                                                               diagram 
 
N                          2                          0                               2                                    4 
Percentage           50%                     0                               50%                             100% 
 
 
 
Offset responsibility. There were no ads which depicted offset responsibility as 
visual cues.  
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Recategorization. Recategorization is operationally defined as social context and 
relational context. First, ads depicting recategorization were divided into 5 medical 
conditions: anti-depression (6.7%), Bipolar disorder (33.3%), Alzheimer‟s disease 
(90.0%), ADHD (87.5%), and Erectile Dysfunction (54.8%). Noticeably, drugs for 4 
medical conditions were included into mental illness. Alzheimer‟s disease is the most 
common ad which used recategorization. ADHD (87.5%) and Erectile Dysfunction 
(54.8%) were the next rank (See Table 13). 
In terms of social context, the majority of social context was romance (66.7%) 
and the next is family (22.2%) among 36 ads (See Table 14). Relational context which 
was defined by the number of people showed that the majority of ads depicted dyad 
(86.1%) (See Table 15). 
To compare the presence of recategorization among medical conditions, a chi-
square analysis was also conducted. The results (See Table 13) showed that that 
recategorization was significantly different between (at the p <0.05 level) medical 
conditions. Alzheimer‟s disease and ADHD offered recategorization more than anti-
depression and bipolar disorder.  
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Table 13- Visual recategorization by medical condition 
  
Medical condition 
 
 Anti-
depression 
 
 
N 
Percent 
 
Bipolar 
disorder 
 
 
N 
Percent 
Alzheimer‟s 
disease 
 
 
N 
Percent 
ADHD 
 
 
 
N 
Percent 
Anxiety 
disorder 
 
 
N 
Percent 
Vaginal 
disease 
 
 
N 
Percent 
Fungal 
skin 
infection 
 
N 
Percent 
Erectile 
dysfunction 
 
 
N 
Percent 
total 
 
Yes 
 
 
 
1 
6.7% 
 
2 
33.3% 
 
9 
90.0% 
 
7 
87.5% 
 
0 
0 
 
0 
0 
 
0 
0 
 
17 
54.8% 
 
36 
45.6% 
No 
 
 
14 
93.3% 
4 
66.7% 
1 
10.0% 
1 
12.5% 
1 
100% 
4 
100% 
4 
100% 
14 
45.2% 
43 
54.4% 
Total 15 
100% 
6 
100% 
10 
100% 
8 
100% 
1 
100% 
4 
100% 
4 
100% 
31 
100% 
79 
100% 
 
Chi-square =31.753(df =7, p= .000) 
 
Table 14- Prevalence of visual recategorization- social context 
 
Visual recategorization (social context) 
                                  Family           Romance          Recreation         Other              Total 
 
N                            8                     24                       3                      1                     36 
Percentage            22.2%             66.7%                8.3%               2.8%               100% 
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Table 15- Prevalence of visual recategorization-relational context 
 
Visual recategorization (relational context) 
                                Alone                      Dyad                      Group                      Total 
 
N                           2                             31                              3                            36 
Percentage            5.6%                     86.1%                      8.3%                        100% 
 
 
 
Research Question Results 
RQ1:  What components of reducing stigma are most prevalent in DTC print ads 
via textual cues?” 45 ads (57%) offered stigma reducing components as textual cues. The 
most prevalent textual cues was  recategorization (32.9%).  
RQ2: “Are there significant differences of textual components of reducing stigma 
among medical conditions?”  There were significant differences in onset controllability 
among medical conditions: depression (66.7%), vaginal disease (50%) and Erectile 
Dysfunction (9.7%) and bipolar disorder (33.3%). Anti-depression ads with onset 
controllability were shown more often than vaginal disease ads and bipolar disorder.  
There were also significant differences in offset responsibility among medical conditions. 
Bipolar disorder (66.7%) and fungal skin infection (50.0%) offered offset responsibility 
more often than anti-depression (6.7%) and erectile dysfunction (3.2%). However, there 
was no difference for the presence of recategorization. 
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RQ3: What components of reducing stigma are most prevalent in DTC print ads 
via visual cues?” The most prevalent visual cues were recategorization (45.6%). Onset 
controllability was 5.1%. Visual cues depicted recategorization more than textual cues. 
However, there was no offset responsibility as visual cues.  
RQ4: “Are there significant differences of visual components of reducing stigma 
among medical conditions?” Onset controllability was depicted in only two categories of 
drugs: anti-depression and bipolar disorder. Therefore, we could not find any differences 
in onset controllability among medical conditions. However, there were significant 
differences in the presence of recategorization among medical conditions. Fungal skin 
infection ads and Alzheimer‟s disease offered offset responsibility more than any other 
medical condition ads.  
 
Discussion and Implication 
Discussion 
This study examined the content of DTC print advertising for 10 years from 
January, 1998 to December, 2008, specifically focusing on stigma reducing components 
such as onset controllability, offset responsibility, and recategorization. Consumers‟ 
health behavior may be motivated by both visual cues and textual cues that contained 
stigma reducing components.  
First, the most significant thing was 63 DTC ads among total 79ads (79.7%) 
which are related to stigmatized disease provided at least one stigma reducing strategy. 
Even though onset controllability and recategorization were relatively low, these two 
components were more than offset responsibility. Moreover, there were no ads which 
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offered simultaneously all three components (onset controllability, offset responsibility 
and recategorization). However, the relative emphasizing of recategorization can cause an 
unbalance of stigma reducing components.  This implies a meaning that Corrigan and 
Penn (1999)‟s strategy of interventions to reduce stigma could not effectively function. 
When a balance of education and contact is conducted, stigma reducing intervention can 
be effective. Therefore, it required appropriate adjustments by onset controllability, offset 
responsibility and recategorization. 
Second, onset controllability was an educational strategy which is one of the 
reducing stigma strategies. However, the result showed that there were not many ads 
which were offering onset controllability. Only four categories of drugs: anti-depression 
(66.7%), bipolar disorder (33.3%), vaginal disease (50%), and erectile dysfunction 
(9.7%) offered cause of illness. 
Obviously, because information such as symptom of disease and side effects of 
the advertised drug occupied a large portion in main text in an ad, this could be an 
educational role. However, in terms of education strategy to reduce stigma, as this result 
showed, onset controllability occupied a small portion in DTC advertising.  
Offset responsibility was another educational strategy to reduce stigma. However, 
the majority ads might not offer the offset responsibility. One of the reasons is that the 
limited characteristic of print ads is insufficient to explain to degree of people‟s coping 
efforts. However, as Schwarzer and Weiner (1991) mentioned, the sole onset 
controllability is insufficient to determine affective and behavioral reactions toward the 
stigmatized. Therefore, efforts to present offset responsibility in print DTC ads is needed. 
Explaining both onset controllability and offset responsibility could reduce stigma. 
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Moreover, insufficient offering of offset responsibility may evoke another 
problem. This will make people perceive DTC drug as quick solutions.  An excessive 
emphasizing of effectiveness of DTC drugs without presenting another coping method 
will cause over-prescribing of DTC drugs.  
Third, recategorization was a contact strategy to reduce stigma. Even though 
textual cues did not offer much recategorization (32.9%), visual cues offered 
recategorization (45.6%). Therefore, visual cues and textual cues play a reciprocal role in 
offering recategorization components.  
Conclusion 
Even though the past ten years of DTC ads of a stigmatized disease since 1998 
have taken efforts to reduce stigma, more efforts are needed for public health 
communication. First, this study showed that onset controllability as education strategy 
was relatively low. The majority of medical conditions did not offer onset controllability. 
Only medical conditions (anti-depression and bipolar disorder) and vaginal disease 
offered onset controllability as both textual cues and visual cues. This study can suggest 
this skewed use of onset controllability among medical conditions has to be changed. The 
offering of onset controllability in other medical condition ads is needed. 
Second, because offset responsibility is another education strategy, the sole 
explanation of onset controllability without offset responsibility cannot be effective as 
educational strategy. 
Third, recategorization was offered as relatively low as textual cues. However, 
visual cues supplemented the textual cues. These visual cues played a role in vicarious 
contact strategy. Therefore, they are reciprocal to each other. The medical condition 
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which depicted recategorization most often compared with other medical conditions was 
mental illness. According to the medical condition, there was a difference of preference 
of components.  
In conclusion, only half of ads which were related to stigmatized medical 
condition offered stigma reducing strategy. This amount means that efforts of DTC ads 
related to stigmatized medical conditions are insufficient in order to reduce stigma. 
Moreover, even ads which offered stigma reducing strategy focused on overwhelming 
unbalanced components. Component balanced ads will be needed in order to maximize 
the ad‟s effectiveness as a public health communication. 
 
Implication 
This paper can contribute to both practitioners and consumers for two reasons. 
First, this paper examined a content-analysis of the past ten years of DTC ads of a 
stigmatized disease since 1998. This evaluated contents of ads after the FDA‟s relaxed 
regulation. The findings from this sample represented strategies useful in reducing stigma 
and influence consumers‟ behaviors while also showing how marketers have made efforts 
to influence those consumers.  
Second, this paper provided theoretical and methodological frameworks for 
investigating features of DTC advertising.  This paper examined the contents that are 
being used in DTC advertising related to stigma as to whether it educates consumers to 
reduce consumers‟ stigma through applying the Attribution theory and Recategorization 
theory. Until now, despite the importance of evaluating content of DTC advertising, there 
have been few studies about evaluating content of DTC advertising based on the theories. 
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This paper examined which persuasive health messages were used in DTC advertising to 
reduce stigma and how DTC advertising considered both visual cues and textual cues 
used. This paper especially examined DTC advertising related to stigmatized diseases: 
mental illness (anti-depression, bipolar disorder, Alzheimer‟s disease, ADHD, and 
anxiety disorder), vaginal disease, fungal skin infection, and Erectile Dysfunction DTC 
print advertisements as to whether they have offered reducing stigma components by 
using Time magazines.  
This study suggests significant educational as well as strategic marketing 
implications. First, this study begins with educational (scholarly) implication. The 
ongoing debate of DTC advertising focuses on whether DTC advertising is a potential 
area for health communication interventions. To the extent that DTC advertising 
influences consumers‟ health behavior, DTC advertising needs to be designed to enable 
consumers to take advantage of DTC advertising‟s beneficial influences and to avoid its 
negative effects by providing information and fulfilling educational functions. This study 
also suggests the need for health communication programs to be designed to make the 
public more critical consumers of DTC advertising for consumers. If the campaign is 
strategically planned based on carefully designed messages, then the chances of a 
successful campaign are maximized. 
Based on this theory, finding the contents that are under- or over- utilized, 
practitioners can design effective messages that will appeal to consumers and pass on 
health messages. Consumers with high stigma and passive behavior will change their 
behavior more actively by reducing stigma. Moreover, through this paper, if the gap 
between theoretical knowledge and message design can be narrowed, it can be very 
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beneficial. If the print DTC advertising has made efforts to reduce barriers like stigma 
and to enhance consumers‟ self-efficacy, it can change the view toward DTC advertising 
from negative to more positive. 
This study also suggests marketing implications. Reducing stigma leads to 
positive marketing outcomes. As consumers become gradually more familiar with the 
stigmatized disease drug, and access to treatment becomes easier, more demands of DTC 
drugs increase. This causes products‟ differentiations or difference between brands. This 
implies how valuable DTC advertising is for the pharmaceutical industry. 
 
Limitation and Future study 
First, a limitation of content analysis is that it cannot demonstrate how consumers 
perceive and interact with media. Therefore, through this study, future study by 
experiment is needed. This study can be a guideline toward future study that will examine 
which content elements of DTC advertising can increase or decrease consumers‟ stigma 
perceptions. This also enables to provide guidelines to FDA. This relates to social 
implications of DTC advertising which transfers more broadly into implications for 
public health. This study suggests the possibility that twisted and exaggerated perception 
of depression can be changed through DTC advertising. Therefore, the effects of specific 
content elements in DTC advertising on reducing stigma should be considered an 
important research topic with implications for pharmaceutical marketing strategies as 
well as public health. Second, this study is limited to print DTC advertising.  
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Second, this study is limited to print DTC advertising. Therefore, a sample of this 
study cannot represent contents of DTC advertising. Future study is needed to examine 
other media such as television and the Internet. 
Third, this study sampled print DTC ads from 1998 to 2008. This period is 
valuable but, in order to examine the effects of FDA‟s relaxed regulation whether FDA‟s 
regulation influence to content of DTC ads or not, further study is needed by comparing 
DTC ads after 1998 with DTC ads before 1998. 
Fourth, future study also is needed to examine the impact of the way presentation 
of prescription drug has because the majority ads offers prescription drug as the way of 
treatment without offering offset responsibility. Understanding how consumers perceive 
the prescription drug according to the way of positioning and whether this perception 
causes stigma reduction or not will suggest new strategies for reducing stigma.  
 
 
 
 
 
 
 
50 
 
References 
Abel, G. A., Lee, S. J., & Weeks, J. C. (2007). Direct-to-Consumer Advertising in 
Oncology: A content analysis of print media. Journal of Clinical Oncology, 
25(10), April 1, 1267-1271. 
Advertising Age (2006). Magazine circulation rankings.  Retrieved from February, 2009 
http://adage.com/datacenter/article?article_id=106355. 
Allison-Ottey, S., Ruffin, K., Allison, K., & Ottey, C. C. (2003). Assessing the impact of 
direct-to-consumer advertisements on the AA patient: A multitude survey of 
patients during the office visit. Journal of the National Medical Association, 95(2), 
120-131. 
Amador, X. F., Strauss, D. H., Yale, S. A., & Gorman, J. M. (1991). Awareness of illness 
in schizophrenia. Schizophrenia Bulletin, 17, 113-132. 
American Stroke Association (Producer). (2005). Early stroke response [Television 
Public Service Announcement]. Dallas, TX: Author. 
Anesbury, T., & Tiggemann. M. (2000). An attempt to reduce negative stereotyping of 
obesity in children by changing controllability beliefs. Health Education Research, 
15(2), 145-152. 
 Anon (1998). Pushing ethical pharmaceuticals direct to the public. Lancer, 351: 921. 
Ball, J. G., Liang, A., & Lee, W. (2008). Reducing stigma through Direct-to-Consumer 
pharmaceutical advertising: A content analysis of television commercials. The 
Association for Education in Journalism & Mass Communication annual 
convention in Chicago, IL on August 9, 2008. 
51 
 
Bandura, A. (1997). Self-efficacy: The exercise of control. New York. NY: W. H. 
Freeman. 
Barth, K. R., Cook, R. L., Downs, J. S., Switzer, G. E., & Fischhoff, B. (2002). Social 
stigma and negative consequences: Factors that influence college students' 
decisions to seek testing for sexually transmitted infections. Journal of American 
College Health, 50(4), 153. 
Bergman, M. E., & Chalkley, K. M. (2007). “Ex” Marks a spot: The stickiness of dirty 
work and other removed stigmas. Journal of Occupational Health Psychology, 
12(3), 251-265. 
Bell, R. A., Wilkes, M. S., & Kravitz, R. L. (2000). The educational value of consumer-
targeted prescription drug print advertising. The Journal of Family Practice, 
49(12), 1092-1098. 
Birdwhistell, R. (1955). Background to kinesis. ETC, 13, 10-18. 
Blankenhorn, K., Duckwitz, N., & Kerr, M. (2001). Power to the people. Medical 
Marketing & Media, 36(8), 66-70.  
Bradley, L. R., & Zito, J. M. (1997). Direct-to-consumer prescription drug advertising. 
Medical Care, 35, 86-92. 
Brewer, M. B. (1979). Ingroup bias in the minimal intergroup situation: A cognitive-
motivational analysis. Psychological Bulletin, 86, 307-324. 
Brewer, M. B., & Miller, N. (1984). Beyond the contact hypothesis: Theoretical 
perspectives on desegregation. In N. Miller & M. B. Brewer (Eds.), Groups in 
contact: The psychology of depression, (281-302), Orlando, FL: Academic Press. 
52 
 
Brockington, I., Hall, P., Levings, J., & Murphy, C. (1993). The community‟s tolerance 
of the mentally ill. British Journal of Psychiatry. 162, 93-99. 
Brown, R. J. (1984). The effects of intergroup similarity and cooperative vs. competitive 
orientation on intergroup discrimination. British Journal of Social Psychology, 23, 
21–33. 
Calfee, J. E. (2002). Public policy issues in direct-to-consumer advertising of prescription 
drugs. Journal of Public Policy & Marketing, 21(2), 174-193. 
Cappella, J. N., Fishbein, M., Hornik, R., Ahern, R. K., & Sayeed, S. (2001). Using 
theory to select message in antidrug media campaigns: Reasoned action and 
media priming. In R.E. Rice & C. K. Atkin (Eds.), Public communication 
Campaigns. (pp. 214-230) Thousand Oaks, CA: Sage. 
Centers for Disease Control and Prevention (2004). Genital HPV Infection Fact Sheet. 
Atlanta, GA;CDC National Prevention Information Network;  Retrieved  April 10. 
2008. From www.cdc.gov/nchstp/dstd/stats_Trends/1999SurvRpt.htm 
Cline, R. J., & Young, H. N. (2004). Marketing drugs, marketing health care relationship: 
A content analysis of visual cues in Direct-to-Consumer prescription drug 
advertising. Health Communication, 16(2), 131-157. 
Corrigan, P. W. (2000). Mental health stigma as social attribution: Implications for 
research methods and attitude change. Clinical Psychology: Science and 
Practice,7, 48-67. 
Corrigan, P. W., Larson, J., Sells, M., Niessen, N., & Watson, A. C. (2007). Will filmed 
presentations of education and contact diminish mental illness stigma? 
Community Mental Health Journal, 43(2), 171-181. 
53 
 
Corrigan, P. W., & Penn, D. L. (1999). Lessons from social psychology on discrediting 
psychiatric stigma. American Psychologist, 54, 765-776. 
Corrigan, P. W., River, L. P., Ludin, R. K., Wasowski, K. U., Campion, J. Mathisen, J., 
Goldstein, H., Gagnon, C., Bergman, M., & Kubiak, M. A. (1999). Predictors of 
participation in campaigns against mental illness stigma. Journal of Nervous and 
Mental Disease, 187, 378-380. 
Corrigan, P. W., Rowan, D., Green, A., Lundin, R., River, P., Uphoff-Wasowski, K., 
White, K., & Kubiak, M. A. (2004). Challenging two mental illness stigmas: 
Personal responsibility and dangerousness. Schizophrenia Bulletin, 28(2), 293-
309. 
Corrigan, P. W., Thompson, V., Lambert, D., & et al (2003). Perceptions of 
discrimination among persons with seriousmental illness. Psychiatric Services, 54, 
1105-1110. 
Corrigan, P. W., & Watson, A. C. (2002). The paradox of self-stigma and mental illness. 
Clinical Psychology. 9, 35-53. 
Corrigan, P. W., & Watson, A. C. (2004). At issue: Stop the stigma: Call mental illness a 
brain disease. Schizophrenia Bulletin, 30(3), 477-479. 
Crandall, C. S. (1994). Prejudice against fat people: ideology and self-interest. Journal of 
personality and social psychology, 66, 882-894. 
Crocker, J., Major, B., & Steele, C. (1998). Social stigma. In: Gilbert, D. T., Fiske, S. T., 
& Lindzey, G. (eds). Handbook of Social Psychology. 4
th
 edn, 2. McGraw-Hills: 
Boston, 504-553. 
54 
 
Davis, J.J. (2000). Riskier than we think? The relationship between risk statement 
completeness and perceptions of direct-to –consumer advertised prescription 
drugs. Journal of Health Communication,5, 349-369.  
Devine, P. G. (1995). Prejudice and out-group perception. In A. Tesser (Ed.), Advanced 
Social Psychology, 466-524, New York: McGraw-Hill. 
Devine, P. G., & Hirt, E. R. (1989). Message strategies for information campaigns: A 
social psychological analysis. In C. T. Salmon (Ed.), Information campaigns: 
Balancing social values and social change (pp. 229-258). Newbury Park, CA: 
Sage. 
Devine, P. G., Plant, E. A., & Harrison, K. (1999). The problem of “Us” versus “Them” 
and AIDS stigma. The American Behavioral Scientist, 42(7), 1212-1228. 
Donohue, J. M , Cevasco, M., & Rosenthal, M. B. (2007). A decade of direct-to-
consumer advertising of prescription drugs. New England Journal of Medicine, 
357(7), 673-681. 
 
 Elliott, C. (2003) Better than Well: American Medicine Meets the American Dream, New 
York: W.W. Norton. 
Findlay, S. D. (2001). Direct-to-consumer promotion of prescription drugs: Economic 
implications for patients, payers, and providers. PharmacoEconomics, 19(2), 109-
119. 
Frosch, D. L., Krueger, P. M., Hornik, R. C., Cronholm, P. F., MSCE, & Barg, F. K. 
(2007). Creating demand for prescription drugs: A content analysis of television 
direct-to-consumer advertising. Annals of Family Medicine 5:6-13 (2007). 
55 
 
Gaertner, S. L., & Dovidio, J. F. (2000). Reducing intergroup bias: The common ingroup 
identity model. Philadelphia: The Psychological Press/Taylor & Francis. 
Gaertner, S. L., & Dovidio, J. F., Anastasio, P. A., Bachman, B. A., & Rust, M. C. (1993). 
The common ingroup identity model: Recategorization and the reduction of 
intergroup. In W. Stroebe & M. Hewstone (Eds.), European review of social 
psychology (Vol. 4, pp. 1–26). New York: Wiley. 
Goffman, E. (1963). Stigma: Notes of the management of spoiled identity. Englewood 
Cliffs, NJ: Prentice-Hall. 
Grow, J. M., Park, J., & Han, X. (2006). “Your life is waiting!” Symbolic meanings in 
Direct-to-Consumer antidepressant advertising. Journal of Communication 
Inquiry, 30(2), 163-188. 
Hewstone, M., Bond, M. H., & Wan, K. C. (1983). Social facts and social attributions: 
The explanation of intergroup differences in Hong Kong. Social Cognition, 2, 
142–157. 
Herek, G. M., & Capitanio, J. P. (1997). AIDS stigma and contact with persons with 
AIDS: Effects of direct and vicarious contact. Journal of Applied Social 
Psychology, 27 (1), 1. 
Hollon, M. F. (1999). Direct-to-consumer marketing of prescription Drugs: Creating 
consumer demand. The Journal of the American Medical Association. 
281(4):382-384. 
Holmer, A. F. (1999). Direct-to-consumer prescription drug advertising builds bridges 
between patients and physicians. Journal of American Medical Association, 
281(4), 380-382.  
56 
 
Holmer, A. F. (2002). Direct-to-consumer advertising – Strengthening our health care 
system. New England Journal of Medicine, 346, 526-528.  
Holmes, E. P., Corrigan, P. W., Williams, P., Canar, J., & Kubiak, M. (1999). Changing 
public attitudes about schizophrenia. Schizophrenia Bulletin, 25, 447-456. 
Howard, J. W., & Rothbart, M. (1980). Social categorization and memory for in-group 
and out-group behavior. Journal of Personality and Social Psychology, 38, 301–
310. 
Huh, J. & Cude, B. J. (2004). Is the information “Fair and Balanced” in direct- to- 
consumer prescription drug Websites? Journal of Health Communication, Vol 9. 
529-540. 
Impotence Association (1997). Survey 1997. London:Taylor Nelson AGB Healthcare. 
Kalichman, S. C., Russell, R. L., Hunter, T. L., & Sarwer, D. B. (1993). Earvin “Magic” 
Johnson‟s HIV serostatus disclosure: Effects on men‟s perceptions of AIDS. 
Journal of Consulting and Clinical Psychology, 61, 887-891. 
Kaphingst, K.A. & Dejong, W. (2004). Market Watch, The educational potential of 
direct-to-consumer prescription drug advertising, Health Affairs, 23(4), 143-150 
Kaphingst, K. A., Rudd, R. E., Dejong, W., & Daltroy, L.H. (2004). Comprehension of 
information in three direct-to-consumer television prescription drug 
advertisements among adult with limited literacy. Journal of Health 
Communication, 10, 609-619. 
Kelly, P. (2004). Perspective: DTC advertising‟s benefits far outweigh its imperfections. 
Health Affairs. 10,1377, 246-248. 
57 
 
King, M., Dinos, S., Shaw, J., et al. (2007). The Stigma Scale: development of a 
standardised measure of the stigma of mental illness. British Journal of 
Psychiatry 190, 248–254. 
Kopp, S.W, & Bang, H. (2000). Benefit and risk information in prescription drug 
advertising: review of empirical studies and marketing implications, Health 
Marketing Quarterly, 17(3), 39-56. 
Link, B. G. & Cullen, F.T. (1986). Contact with the mentally ill and perceptions of how 
dangerous they are. Journal of Health and Social Behavior, 27, 289-303. 
Link, B. G. & Phelan, J. C. (2001). Conceptualizing Stigma. Annual review of sociology, 
27(1), 363. 
Macias, W. & Lewis, L. S. (2003). A content analysis of Direct-to-Consumer (DTC) 
prescription drug web sites.  Journal of Advertising, 32(4), 43-56. 
Medical Marketing & Media (MM&M). pharma report 2008. Retrieved February, 2009 
from www.mmm-online.com. 
Melman, A, Gingell, J.C. (1999). The epidemiology and pathophysiology of erectile 
dysfunction. J Urol.161:5-11. 
Moreland, R.B., Hsien, G., Nakane, M., & Brioni, J.D. (2001). The biochemical and 
neurologic basis for the treatment of male erectile dysfunction. The Journal of 
Pharmacology  and Experimental Therapeutics, 296(2), 225-234. 
Nier, J. A., Gaertner, S. L., Dovidio, J. F.,  Banker, B. S., Ward, C. M., & Rust, M. C. 
(2001). Changing interracial evaluations and behavior: The effects of a common 
group identity, Group Processes Intergroup Relations, 4(4), 299-316. 
58 
 
NIHCM (National Institute for Health Care Management Research and Education 
Foundation). (2001). Prescription drugs and mass media advertising, 2000. 
Retrieved November 30, 2005, from www.nihcm.org   
Perri, M., & Dickson, W. M. (1988). Consumer reaction to a direct-to-consumer 
prescription drug advertising campaign. Journal of Health Care Marketing, 8(2), 
66-69.  
Rush, L. L. (1998). Affective reactions to multiple social stigmas. Journal of Social 
Psychology, 138, 421-430. 
Schmidt, G., & Weiner, B. (1988). An attribution-affect-action theory of behavior: 
Replications of judgements of help-giving. Personality and Social Psychology 
Bulletin, 14, 610-621. 
Schwarzer, R., & Weiner, B. (1991). Stigma controllability and coping as predictors of 
emotions and social support. Journal of Social and Personal Relationships, 8, 
133-140. 
Sherif, M., Harvey, O. J., White, B. J., Hood, W. R., & Sherif, C. W. (1961). Intergroup 
conflict and cooperation: The Robbers Cave experiment. Norman, OK: University 
of Oklahoma Book Exchange. 
Sirey, J., Bruce, M. L., Raue, P., et al.(2001). Psychological barriers in young and older 
outpatients with depression as predictor of treatment discontinuation. American 
Journal of Psychiatry, 158; 479-481. 
Stephenson, M. T. (2002). Anti-drug public service announcements targeting parents: An 
analysis and evaluation. Southern Communication Journal, 67(4), 335-350. 
59 
 
Stephenson, M. T., & Quick, B. L. (2005). Parent ads in the national youth anti-drug 
media campaign. Journal of Health Communication, 10, 701-710. 
Stevenson, R. W. (1991, November 8). Magic Johnson ends his career, saying he has the 
AIDS virus. New York Times, pp. Al, B 14. 
Tarango, D. (2007). Two case reports: Treating common nail diseases and injuries. The 
Journal of Science and Healing, 3(5), 503-505 
Weiner, B. (1980). A cognitive (attribution)-emotion-action model of motivated 
behavior: An analysis of judgements of helping-giving. Journal of Personality 
and Social Psychology, 39, 186-200. 
Weiner, B. (1985). An attributional theory of achievement motivation and emotion. 
Psychological Review, 92, 548-573. 
Weiner, B. (1986). An attributional theory of motivation and emotion. Berlin: Springer-
Verlag. 
Weiner, B. (1988). Attribution theory and attribution therapy: Some theoretical 
observations and suggestions. British Journal of Psychology, 27, 99-104. 
Weiner, B. (1993). On sin versus sickness: A theory of perceived responsibility and 
social motivation. American Psychologist, 48,957-965. 
Weiner, B. (1995). Judgments of responsibility: A foundation for a theory of social 
conduct. New York: Guilford Press. 
Weiner, B., Perry, R.P., & Magnusson, J. (1988). An attributional analysis of reactions to 
stigmas. Journal of Personality and Social Psychology, 55, 738-748. 
Wiese, H. J., Wilson, J. F., Jones, R. A., & Neises, M. (1992). Obesity stigma reduction 
in medical students. International Journal of Obesity,16, 859-868. 
60 
 
Zucker, G. S., & Weiner, B. (1993). Conservatism and perceptions of poverty: An 
attributional analysis. Journal of Applied Social Psychology, 23, 925-943. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
61 
 
Appendix 
 
1. Publication: time magazine 
2. Period: January 12, 1998 – December 22, 2008 
3. Direct-to-Consumer  advertising  
4. Unit of analysis; each advertisement 
   Coding scheme 
1. Factorial information of advertising 
 
1. Category of drug 
(1) Anti-depression (2) bipolar disorder (3) Alzheimer’s disease (4) ADD (5) anxiety 
disorder  
(6)  Vaginal disease (7) fungal skin infection (8) Erectile Dysfunction (ED) 
1-1. Brand name  
 
(1) Prozac  1 (2) Prozac 2 (3) Prozac 3  
(4) Paxil 1 (5) Paxil 2 (6) Paxil 3 
 (7) Cymbalta 1 (8) Cymbalta 2 (9) Cymbalta 3 (10) Cymbalta 4 (11) Cymbalta 5 (12) 
Cymbalta 6 
(13) Wellbutrin XL 1 
(14) Zoloft 1 (15) Zoloft 2      (1-15; anti-depression) 
(16) Abilify 1 (17) Abilify 2 (18) Abilify 3 (19) Abilify 4 (20) Abilify 5  
(21) Seroquel 1     (16-21; bipolar disorder) 
(22) Aricept 1 (23) Aricept 2 (24) Aricept 3 (25) Aricept 4 (26) Aricept 5 (27) Aricept 6  
(28) Aricept 7 (29) Aricept 8 (30) Aricept 9 (31) Aricept 10   (22- 31; Alzheimer’s disease) 
(32) ADDERALL XR 1 (33) ADDERALL XR 2 (34) ADDERALL XR 3 (35) ADDERALL XR 4 
(36) ADDERALL XR 5  
(37) Vyvanse 1 (38) Vyvanse 2 
(39) Strattera 1    (32-39; ADHD) 
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(40) Buspar 1   (anxiety disorder) 
(41) Diflucan 1  
(42) Gardasil 1  
(43) PREMPRO 1 (44) PREMPRO 2      (41-44; vaginal disease) 
(45) Lamasil 1 (46) Lamasil 2 (47) Lamasil 3 (48) Lamasil 4    (45-48; fungal skin infection) 
(49) Viagra 1 (50) Viagra 2 (51) Viagra 3 (52) Viagra 4 (53) Viagra  5 (54) Viagra  6 (55) 
Viagra  7 (56) Viagra  8 (57) Viagra 9 (58) Viagra 10 (59) Viagra 11 (60) Viagra 12 (61) 
Viagra 13  
(62) Viagra 14 (63) Viagra 15 (64) Viagra 16 (65) Viagra 17 (66) Viagra 18 (67) Viagra 19  
(68) Viagra 20 (69) Viagra 21 (70) Viagra 22 (71) Viagra 23    
(72) Cialis 1 (73) ) Cialis 2 (74) Cialis 3 (75) Cialis 4 (76) Cialis 5 (77) Cialis 6 
(78) Levitra 1 (79) Levitra 2   (49-79; Erectile Dysfunction) 
 
1-2. Generic Product name 
(1) Fluoxetine hydrochloride (2)parozetine HCI (3)sertraline HCI (4) duloxetine HCI 
 (5) bupropion HCI (6) aripiprazole (Abilify) (7)quetiapine fumarate (seroquel) 
(8) donepezil HCI (Aricept)  (9) mixed salts of a single-entity amphetamine product 
(ADDERALL XR) 
(10) lisdexamfetamine dimesylate (Vyvanse) (11) atomoxetine HCI (Strattera)  (12) buspiron 
HCI 
(13) Fluconazole tablet (Diflucan) (14) Quadravalent Human Papillomavirus vaccine  
(15) conjugate estrogens/medroxyprogesterone acetate tablets (PREMPRO) 
(16) terbinafine HCI tablets  (17)sildenafil citrate  (18) tadalafil (Cialis) (19) vardenafil HCI 
 
1-3. Manufacturer 
(1) Lilly ICOS, Indianapolis, Ind  (2) GlaxoSmithKline, Middlesex, UK (3) Pfizer, New York, NY 
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(4)  Otsuka America Pharmaceutical, Inc. (Abilify) (5) AstraZeneca (Seroquel) 
(6) Shire  (7) Merck & Co. Inc  (8) Wyeth Pharmaceutical Inc. (9) Novartis  
      
1-4. type of cues 
       (1) visual cues   (2) textual cues 
(2) Characteristics of Content  
 
2-1. Categories of visual cues 
(1)  onset controllability 
(2)  offset responsibility 
(3 ) recategorization 
 
2-1-1. onset controllability 
(1) Picture of biological organs or symptoms 
(2) Graphical framing of disease as chemically bound 
(3) Symbolically informational medicalized diagram 
 
2-1-2. offset responsibility (effort to coping with)  
(1) Efforts to cope with (such as exercising, therapy) 
 
               2-1-3. recategorization 
(1)    Social context ( two or more people) 
(1.1) Family (depicting people from two generation) 
(1.2) Romance (depicting only two people engaged in embracing or mutual gazing) 
(1.3) Work (reflected in work-related clothing and /or equipment) 
(1.4) Recreational (relaxing) 
(1.5) Other (indeterminate) 
 
(2) Relational context ( number of people depicted) 
(2.1) alone 
(2.2) dyad 
(2.3) group 
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2-2. Categories of textual cues 
(1) Onset controllability 
(2) Offset responsibility 
(3) Recategorization 
 
 
 
2-2-1. onset controllability 
(1) Cause of illness as biological or biomedical problem 
(2) That’s not true (change attribution) 
2-2-2. offset responsibility 
                (1) coping with 
(1)implied coping effort 
(2) direct coping effort 
 
  (2)Solution 
(1) Not Presenting other alternative ways 
(2) Presenting other alternative ways 
 
(2-1) way of medicine positioning 
(1) A prescription drug  (one of drug) 
(2) The prescription drug  
(3) Only one prescription drug 
(4) Best #1 prescription drug 
(5) Best possible 
(6) Better 
(7) Especially good 
(8) Good 
(9) Subjective qualities 
              2-2-3. recategorization 
(1) We, our, us or you are not alone, You’re not different person 
(2) Join 
 
 
65 
 
66 
 
 
